Astera Labs Initiated at Outperform with $225 Price Target by BNP Paribas Exane
Astera Labs has been initiated with an 'Outperform' rating by BNP Paribas Exane. Additionally, BNP Paribas Exane has set a price target of $225.00 per share for Astera Labs. This indicates a positive outlook on the company's stock performance.